We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
+$39.1M
Cap. Flow
+$31.7M
Cap. Flow %
11.59%
Top 10 Hldgs %
48.97%
Holding
857
New
152
Increased
203
Reduced
148
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 3.86%
2 Consumer Discretionary 2.69%
3 Industrials 1.78%
4 Consumer Staples 1.62%
5 Energy 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSS icon
626
Kohl's
KSS
$2.19B
$2.77K ﹤0.01%
120
AJRD
627
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$2.74K ﹤0.01%
50
RIVN icon
628
Rivian
RIVN
$23.1B
$2.58K ﹤0.01%
155
FDLS icon
629
Inspire Fidelis Multi Factor ETF
FDLS
$240M
$2.56K ﹤0.01%
+94
New +$2.37K
OPFI icon
630
OppFi
OPFI
$585M
$2.55K ﹤0.01%
1,250
BSCN
631
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$2.54K ﹤0.01%
120
IBTD
632
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
$2.48K ﹤0.01%
100
BSCO
633
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$2.47K ﹤0.01%
120
STZ icon
634
Constellation Brands
STZ
$22.9B
$2.46K ﹤0.01%
+10
New +$2.34K
NXPI icon
635
NXP Semiconductors
NXPI
$58.9B
$2.46K ﹤0.01%
12
QQQM icon
636
Invesco NASDAQ 100 ETF
QQQM
$103B
$2.43K ﹤0.01%
16
TRI icon
637
Thomson Reuters
TRI
$44.5B
$2.43K ﹤0.01%
18
-1
-5% -$134
VALE icon
638
Vale
VALE
$61.4B
$2.4K ﹤0.01%
179
-942
-84% -$13.3K
IBTE
639
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
$2.38K ﹤0.01%
100
APLS
640
DELISTED
Apellis Pharmaceuticals
APLS
$2.37K ﹤0.01%
26
+25
+2,500% +$2.16K
REPL icon
641
Replimune Group
REPL
$1.28B
$2.32K ﹤0.01%
+100
New +$1.95K
GILD icon
642
Gilead Sciences
GILD
$168B
$2.31K ﹤0.01%
+30
New +$2.39K
KODK icon
643
Kodak
KODK
$992M
$2.31K ﹤0.01%
500
LIT icon
644
Global X Lithium & Battery Tech ETF
LIT
$1.61B
$2.28K ﹤0.01%
35
+25
+250% +$1.56K
MET icon
645
MetLife
MET
$61.4B
$2.26K ﹤0.01%
40
-31
-44% -$1.72K
CTEX icon
646
ProShares S&P Kensho Cleantech ETF
CTEX
$5.34M
$2.21K ﹤0.01%
65
NCLH icon
647
Norwegian Cruise Line
NCLH
$8.69B
$2.18K ﹤0.01%
100
UAA icon
648
Under Armour
UAA
$2.26B
$2.17K ﹤0.01%
300
ILF icon
649
iShares Latin America 40 ETF
ILF
$3.71B
$2.15K ﹤0.01%
79
RSP icon
650
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$2.1K ﹤0.01%
14
-195
-93% -$28.1K

Similar funds

Oliver Lagore Vanvalin Investment Group's Q2 2023 Portfolio in Review

As of Q2 2023, Oliver Lagore Vanvalin Investment Group held 857 positions worth $273M, up 17% from $234M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Oliver Lagore Vanvalin Investment Group deployed $31.7M of net new capital in Q2 2023, opening 152 new positions and adding to 203 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 395,541 shares worth $7.71M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $17.9M trimmed.

  • Oliver Lagore Vanvalin Investment Group's largest Q2 2023 buy was Invesco Emerging Markets Sovereign Debt ETF: 395,541 shares worth $7.71M.
  • Oliver Lagore Vanvalin Investment Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $17.9M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q2 2023 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $17.9M.
  • Oliver Lagore Vanvalin Investment Group fully exited Albemarle in Q2 2023, selling an estimated $83.3K.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 49% of its $273M portfolio in Q2 2023.
  • Oliver Lagore Vanvalin Investment Group opened 152 new positions and closed 82 in Q2 2023.
  • Oliver Lagore Vanvalin Investment Group's portfolio value rose 17% quarter-over-quarter to $273M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2023, filed 8 Aug 2023.